The Latest

COUR Pharmaceuticals Secures FDA Clearance of IND Application for CNP-103 in Type 1 Diabetes

Skip to primary navigation
Skip to main content
Skip to footer

COUR Pharmaceuticals

Our Company
Our Technology
- Pipeline
Our Clinical Trials
- CNP-106 Myasthenia Gravis
Publications & Media
- Press Releases
- Publications
Careers

Cour Pharma Presents Scientific Poster on Breakthrough Celiac Treatment at 16th Annual International Celiac Disease Symposium

Download Poster Here

Footer

Our Company
Our Technology
Our Partners
Press
Careers

©

2025

COUR Pharmaceuticals.
All Rights Reserved.

Privacy Policy • Terms of Use